Suppr超能文献

肝细胞癌中杂合性缺失与p53基因突变分析

Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma.

作者信息

Yumoto Y, Hanafusa T, Hada H, Morita T, Ooguchi S, Shinji N, Mitani T, Hamaya K, Koide N, Tsuji T

机构信息

Isotope Center, Okayama University, Japan.

出版信息

J Gastroenterol Hepatol. 1995 Mar-Apr;10(2):179-85. doi: 10.1111/j.1440-1746.1995.tb01075.x.

Abstract

Thirty-six hepatocellular carcinoma (HCC) tissues obtained from 34 patients were classified according to histological diagnosis into six well-differentiated HCC, 20 moderately differentiated HCC and 10 poorly differentiated HCC. High molecular weight DNA was prepared from each tumour and the corresponding non-tumour tissue. Loss of heterozygosity (LOH) on chromosomes 4q, 5q, 10q, 11p, 16q, 17p, mutation of the p53 gene and polymorphism of intron 25 of the retinoblastoma (RB) gene were simultaneously analysed. The patients were composed of three cases of small HCC (the diameter of which was < 3 cm) and 31 cases of advanced HCC. Twenty-nine of 34 (85.3%) patients analysed had been exposed to hepatitis B virus and/or hepatitis C virus. The frequencies of LOH on seven chromosomes were 57.9% in 17p13.3, 45.1% in 17p, 45.1% in 11p, 41.9% in 5q, 41.9% in 16q24, 29.0% in 4q, 25.8% in 10q in advanced HCC (four of well differentiated, 18 of moderately differentiated and nine of poorly differentiated carcinoma). In contrast, LOH was observed on 4q, 5q, 16q and 17p in 33% (1/3) of the small HCC (two of well differentiated and one of moderately differentiated carcinoma). The mutation of the p53 genes and polymorphism of the RB gene were present in 25.8% (8/31) and 12.9% (4/31) of the advanced tumours, respectively, but the mutation was not found in small HCC. LOH on every chromosome and the p53 mutation were observed more frequently in more advanced tumours, and the genetic changes accumulated with the increase of the histopathological grade.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

从34例患者获取的36份肝细胞癌(HCC)组织,根据组织学诊断分为6份高分化HCC、20份中分化HCC和10份低分化HCC。从每个肿瘤组织及相应的非肿瘤组织中提取高分子量DNA。同时分析4号染色体长臂(4q)、5号染色体长臂(5q)、10号染色体长臂(10q)、11号染色体短臂(11p)、16号染色体长臂(16q)、17号染色体短臂(17p)的杂合性缺失(LOH)、p53基因的突变以及视网膜母细胞瘤(RB)基因内含子25的多态性。患者包括3例小肝癌(直径<3 cm)和31例进展期肝癌。34例接受分析的患者中有29例(85.3%)曾接触过乙型肝炎病毒和/或丙型肝炎病毒。进展期肝癌(4例高分化、18例中分化和9例低分化癌)中,7条染色体上LOH的频率分别为:17p13.3处为57.9%、17p处为45.1%、11p处为45.1%、5q处为41.9%、16q24处为41.9%、4q处为29.0%、10q处为25.8%。相比之下,小肝癌(2例高分化和1例中分化癌)中有33%(1/3)在4q、5q、16q和17p处观察到LOH。进展期肿瘤中p53基因的突变和RB基因的多态性分别占25.8%(8/31)和12.9%(4/31),但小肝癌中未发现p53基因突变。在更进展期的肿瘤中,各染色体上的LOH和p53突变更频繁地被观察到,并且遗传改变随着组织病理学分级的增加而累积。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验